X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (264) 264
Publication (43) 43
Book / eBook (4) 4
Newspaper Article (2) 2
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (104) 104
humans (96) 96
female (74) 74
male (73) 73
middle aged (65) 65
adult (63) 63
hematology (57) 57
aged (56) 56
life sciences (35) 35
aged, 80 and over (31) 31
oncology (29) 29
cancer (23) 23
chemotherapy (23) 23
retrospective studies (23) 23
treatment outcome (23) 23
research (22) 22
young adult (22) 22
rituximab (20) 20
disease-free survival (19) 19
adolescent (18) 18
analysis (18) 18
ghana (17) 17
medicine (17) 17
risk factors (17) 17
abridged index medicus (16) 16
research article (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
survival (15) 15
follow-up studies (14) 14
human health and pathology (14) 14
lymphoma (14) 14
prospective studies (14) 14
therapy (14) 14
medical research (13) 13
survival rate (13) 13
[ sdv.can ] life sciences [q-bio]/cancer (12) 12
hemic and lymphatic diseases (12) 12
lymphomas (12) 12
non-hodgkins-lymphoma (12) 12
prognosis (12) 12
remission induction (12) 12
health aspects (11) 11
infectious diseases (11) 11
leukemia (11) 11
[sdv.can]life sciences [q-bio]/cancer (10) 10
immunology (10) 10
patients (10) 10
recurrence (10) 10
combined modality therapy (9) 9
diagnosis (9) 9
time factors (9) 9
transplantation (9) 9
trial (9) 9
antineoplastic agents - therapeutic use (8) 8
care and treatment (8) 8
efficacy (8) 8
neoplasm staging (8) 8
progression-free survival (8) 8
science (8) 8
transplantation, autologous (8) 8
acute myeloid leukemia (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
b-cell lymphoma (7) 7
children (7) 7
classification (7) 7
cross-sectional studies (7) 7
cyclophosphamide (7) 7
hematology, oncology and palliative medicine (7) 7
infant (7) 7
management (7) 7
mds (7) 7
medicine, experimental (7) 7
medicine, general & internal (7) 7
multicenter (7) 7
multidisciplinary sciences (7) 7
myelodysplastic syndromes (7) 7
pharmacology & pharmacy (7) 7
risk (7) 7
stem cell transplantation (7) 7
survival analysis (7) 7
[sdv]life sciences [q-bio] (6) 6
acute myeloid-leukemia (6) 6
animals (6) 6
antibodies, monoclonal, murine-derived - administration & dosage (6) 6
article (6) 6
cytarabine - administration & dosage (6) 6
disease (6) 6
drug administration schedule (6) 6
health sciences (6) 6
high-dose methotrexate (6) 6
high-dose therapy (6) 6
immune system diseases (6) 6
infant, newborn (6) 6
interferon (6) 6
medicine & public health (6) 6
methotrexate (6) 6
mortality (6) 6
pregnancy (6) 6
primary cns lymphoma (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 23, pp. 3194 - 3200
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, p. e0185303
Introduction Plasmodium falciparum induced antibodies are key components of anti-malarial immunity in malaria endemic areas, but their antigen targets can be... 
ERYTHROCYTE-BINDING ANTIGEN-175 | APICAL MEMBRANE ANTIGEN-1 | VACCINE CANDIDATE | PROTECTION | CLINICAL MALARIA | ACQUIRED-IMMUNITY | MULTIDISCIPLINARY SCIENCES | PLASMODIUM-FALCIPARUM ANTIGENS | MEROZOITE ANTIGENS | SEROLOGICAL MARKERS | HETEROLOGOUS STRAINS | Antibody Specificity | Antigens, Protozoan - immunology | Humans | Child, Preschool | Infant | Male | Plasmodium falciparum - immunology | Protozoan Proteins - genetics | Malaria, Falciparum - transmission | Antibodies, Protozoan - blood | Plasmodium falciparum - genetics | Malaria, Falciparum - epidemiology | Immunoassay - methods | Female | Antigens, Protozoan - genetics | Seasons | Child | Amino Acid Sequence | Membrane Proteins - genetics | Membrane Proteins - immunology | Ghana - epidemiology | Cross Reactions | Animals | Malaria, Falciparum - immunology | Longitudinal Studies | Protozoan Proteins - immunology | Cohort Studies | Measurement | Viral antibodies | Disease transmission | Malaria | Distribution | Antibodies | Physiological aspects | Development and progression | Research | Multiplexing | Vector-borne diseases | Health sciences | Medical research | Antigens | Parasitology | Immunoglobulins | Health services | Erythrocytes | Biochemistry | Infections | Parasites | Immunity | Proteins | Studies | Immunology | Trends | Children | Molecular biology
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 19, pp. 1916 - 1927
Journal Article
Haematologica, ISSN 0390-6078, 07/2012, Volume 97, Issue 7, pp. 1085 - 1091
Journal Article
Haematologica, ISSN 0390-6078, 08/2011, Volume 96, Issue 8, pp. 1128 - 1135
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2018, Volume 183, Issue 1, pp. 76 - 86
Journal Article
The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 747 - 757
Tyrosine kinase inhibitors (TKIs) have improved the survival of patients with chronic myeloid leukaemia. Many patients have deep molecular responses, a... 
d_article_not_yet_freely_accessible | SURVIVAL | MAJOR MOLECULAR RESPONSE | TREATMENT-FREE REMISSION | ONCOLOGY | IMATINIB DISCONTINUATION | DISEASE | FOLLOW-UP | DASATINIB | WITHDRAWAL SYNDROME | NILOTINIB | PHASE-2 TRIAL | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Clinical Decision-Making | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Polymerase Chain Reaction | Adult | Female | Biomarkers, Tumor - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Drug Administration Schedule | Risk Assessment | Europe | Risk Factors | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Progression-Free Survival | Fusion Proteins, bcr-abl - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Antimitotic agents | Tyrosine | Antineoplastic agents | Analysis | Life Sciences | Hematology | Human health and pathology | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article